⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IMNM News
Immunome, Inc.
Immunome Announces Proposed Public Offering of Common Stock
businesswire.com
IMNM
Immunome Announces Positive Topline Results from Phase 3 RINGSIDE Trial of Varegacestat in Patients with Desmoid Tumors
businesswire.com
IMNM
Immunome to Announce Topline Results from Phase 3 RINGSIDE Trial of Varegacestat in Patients with Desmoid Tumors
businesswire.com
IMNM
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
IMNM
Immunome to Present at Upcoming Investor Conferences
businesswire.com
IMNM
Immunome Reports Third Quarter 2025 Financial Results and Provides Business Update
businesswire.com
IMNM
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
IMNM
Immunome to Present at 2nd Annual Guggenheim Healthcare Innovation Conference
businesswire.com
IMNM
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
IMNM